These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 31484596)

  • 1. A selective sphingomyelin synthase 2 inhibitor ameliorates diet induced insulin resistance
    Huang Y; Huang T; Zhen X; Li Y; Mo M; Ye D; Cheng N
    Pharmazie; 2019 Sep; 74(9):553-558. PubMed ID: 31484596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of sphingomyelin synthase (SMS) affects intracellular sphingomyelin accumulation and plasma membrane lipid organization.
    Li Z; Hailemariam TK; Zhou H; Li Y; Duckworth DC; Peake DA; Zhang Y; Kuo MS; Cao G; Jiang XC
    Biochim Biophys Acta; 2007 Sep; 1771(9):1186-94. PubMed ID: 17616479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery, synthesis and anti-atherosclerotic activities of a novel selective sphingomyelin synthase 2 inhibitor.
    Li Y; Huang T; Lou B; Ye D; Qi X; Li X; Hu S; Ding T; Chen Y; Cao Y; Mo M; Dong J; Wei M; Chu Y; Li H; Jiang XC; Cheng N; Zhou L
    Eur J Med Chem; 2019 Feb; 163():864-882. PubMed ID: 30580239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urotensin II-induced insulin resistance is mediated by NADPH oxidase-derived reactive oxygen species in HepG2 cells.
    Li YY; Shi ZM; Yu XY; Feng P; Wang XJ
    World J Gastroenterol; 2016 Jul; 22(25):5769-79. PubMed ID: 27433090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery and characterization of selective human sphingomyelin synthase 2 inhibitors.
    Adachi R; Ogawa K; Matsumoto SI; Satou T; Tanaka Y; Sakamoto J; Nakahata T; Okamoto R; Kamaura M; Kawamoto T
    Eur J Med Chem; 2017 Aug; 136():283-293. PubMed ID: 28505533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effects of rutin on liver injury in type 2 diabetic db/db mice.
    Liang W; Zhang D; Kang J; Meng X; Yang J; Yang L; Xue N; Gao Q; Han S; Gou X
    Biomed Pharmacother; 2018 Nov; 107():721-728. PubMed ID: 30138894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic modification of sphingomyelin in lipid microdomains controls development of obesity, fatty liver, and type 2 diabetes.
    Mitsutake S; Zama K; Yokota H; Yoshida T; Tanaka M; Mitsui M; Ikawa M; Okabe M; Tanaka Y; Yamashita T; Takemoto H; Okazaki T; Watanabe K; Igarashi Y
    J Biol Chem; 2011 Aug; 286(32):28544-55. PubMed ID: 21669879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spleen-kidney supplementing formula alleviates insulin resistance via regulating AKT/glycogen synthase kinase 3β pathway in rats with type 2 diabetic induced by high-fat diet.
    Tian C; Wang Y; La X; Li J; Zhang B
    J Tradit Chin Med; 2019 Apr; 39(2):199-206. PubMed ID: 32186042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sphingomyelin synthase 2 is one of the determinants for plasma and liver sphingomyelin levels in mice.
    Liu J; Zhang H; Li Z; Hailemariam TK; Chakraborty M; Jiang K; Qiu D; Bui HH; Peake DA; Kuo MS; Wadgaonkar R; Cao G; Jiang XC
    Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):850-6. PubMed ID: 19286635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of the selective sphingomyelin synthase 2 inhibitors with the novel structure of oxazolopyridine.
    Qi XY; Cao Y; Li YL; Mo MG; Zhou L; Ye DY
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3511-3515. PubMed ID: 28619536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin ameliorates PA-induced insulin resistance through the IRS/AKT/FOXO1 and GSK-3β signaling pathway, and inhibits the inflammatory response in HepG2 cells.
    Zhang H; Ge Z; Tang S; Meng R; Bi Y; Zhu D
    Mol Med Rep; 2017 Aug; 16(2):2295-2301. PubMed ID: 28656239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Krüppel-like factor 14 increases insulin sensitivity through activation of PI3K/Akt signal pathway.
    Yang M; Ren Y; Lin Z; Tang C; Jia Y; Lai Y; Zhou T; Wu S; Liu H; Yang G; Li L
    Cell Signal; 2015 Nov; 27(11):2201-8. PubMed ID: 26226221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reducing plasma membrane sphingomyelin increases insulin sensitivity.
    Li Z; Zhang H; Liu J; Liang CP; Li Y; Li Y; Teitelman G; Beyer T; Bui HH; Peake DA; Zhang Y; Sanders PE; Kuo MS; Park TS; Cao G; Jiang XC
    Mol Cell Biol; 2011 Oct; 31(20):4205-18. PubMed ID: 21844222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Casein glycomacropeptide-derived peptide IPPKKNQDKTE ameliorates high glucose-induced insulin resistance in HepG2 cells via activation of AMPK signaling.
    Song JJ; Wang Q; Du M; Li TG; Chen B; Mao XY
    Mol Nutr Food Res; 2017 Feb; 61(2):. PubMed ID: 27506476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baicalin attenuates high fat diet-induced insulin resistance and ectopic fat storage in skeletal muscle, through modulating the protein kinase B/Glycogen synthase kinase 3 beta pathway.
    Xi YL; Li HX; Chen C; Liu YQ; Lv HM; Dong SQ; Luo EF; Gu MB; Liu H
    Chin J Nat Med; 2016 Jan; 14(1):48-55. PubMed ID: 26850346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Role for Ceramides, but Not Sphingomyelins, as Antagonists of Insulin Signaling and Mitochondrial Metabolism in C2C12 Myotubes.
    Park M; Kaddai V; Ching J; Fridianto KT; Sieli RJ; Sugii S; Summers SA
    J Biol Chem; 2016 Nov; 291(46):23978-23988. PubMed ID: 27703011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triterpenic acids-enriched fraction from Cyclocarya paliurus attenuates insulin resistance and hepatic steatosis via PI3K/Akt/GSK3β pathway.
    Zheng X; Zhao MG; Jiang CH; Sheng XP; Yang HM; Liu Y; Yao XM; Zhang J; Yin ZQ
    Phytomedicine; 2020 Jan; 66():153130. PubMed ID: 31790897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SMS overexpression and knockdown: impact on cellular sphingomyelin and diacylglycerol metabolism, and cell apoptosis.
    Ding T; Li Z; Hailemariam T; Mukherjee S; Maxfield FR; Wu MP; Jiang XC
    J Lipid Res; 2008 Feb; 49(2):376-85. PubMed ID: 17982138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the role of sphingomyelin synthase 2 in glucose metabolism in whole-body and peripheral tissues in mice.
    Sugimoto M; Shimizu Y; Zhao S; Ukon N; Nishijima K; Wakabayashi M; Yoshioka T; Higashino K; Numata Y; Okuda T; Tamaki N; Hanamatsu H; Igarashi Y; Kuge Y
    Biochim Biophys Acta; 2016 Aug; 1861(8 Pt A):688-702. PubMed ID: 27151272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of 4-Benzyloxybenzo[ d]isoxazole-3-amine Derivatives as Highly Selective and Orally Efficacious Human Sphingomyelin Synthase 2 Inhibitors that Reduce Chronic Inflammation in db/ db Mice.
    Mo M; Yang J; Jiang XC; Cao Y; Fei J; Chen Y; Qi X; Chu Y; Zhou L; Ye D
    J Med Chem; 2018 Sep; 61(18):8241-8254. PubMed ID: 30074791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.